Fact CheckerSign in

NCT07467473Enrolling by invitation

Causal Role of Rostromedial Prefrontal Cortex for Positive Savoring in Depression

Source: ClinicalTrials.gov · Last updated 20 May 2026

Brief summary (registry, in English)

This is a non-invasive brain stimulation and neuroimaging study that will examine how activity in the medial prefrontal cortex influences reward processing, particularly positive savoring, in individuals with depression. The central question is whether modulating medial prefrontal brain regions using transcranial magnetic stimulation (TMS) alters neural and behavioral responses to rewards. Brain activity will be recorded using both electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) while participants perform reward tasks. The primary objectives are to (1) identify patterns of brain activity linked to impaired reward processing in depression using EEG and fMRI, and (2) determine the causal role of specific prefrontal areas in these processes through targeted TMS. The methods include four sessions over four weeks: a clinical assessment, EEG recording during reward tasks after participants learn/practice positive savoring, an fMRI session, and a TMS session combined with EEG while participants practice positive savoring and perform reward tasks during EEG.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
48 (estimated)
First submitted
9 Mar 2026
Start date
23 Mar 2026
Primary completion date
30 Jun 2028
Lead sponsor
Florida State University
Diseases
Depression
NCT number
NCT07467473

What you commit to

  • Study type: Interventional
  • Planned participants: 48
  • From 23 Mar 2026 to the primary completion date, 30 Jun 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior brain surgery

Other illness

  • Neurological disorders and conditions. Including but not limited to: history of epilepsy, seizures (except childhood febrile seizures), dementia, history of stroke, Parkindon's disease, multiple sclerosis, cerebral aneurysm, brain tumors
  • Medical or neurological illness or treatment for a medical disorder that could interfere with study participation. For example, unstable cardiac disease, HIV/AIDS, malignancy, liver or renal impairment
  • Any brain devices/implants, including cochlear implants and aneurysm clips, cardiac pacemaker, or any other implanted electronic device
  • History of current traumatic brain injury
  • DSM-5 diagnosis of present moderate or severe substance use disorder or alcohol use disorder, and past severe substance use disorder or alcohol use disorder, bipolar disorder, or psychotic disorder
  • Based on the use of MRI, additional exclusion criteria are considered. These include participants having ferrous metal in their body, having non-removable jewelry that is ferrous, having tattoos on the face or neck, history of being a metal worker or having an eye injury involving metal

Other

  • ADHD (currently under treatment)
  • Pregnancy (for females)
  • Claustrophobia
  • Anything that in the opinion of the investigator would place the participant at increased risk or preclude the participant's full compliance with or completion of the study

Who the study is looking for

  • Between the ages of 18 and 65
  • Able to provide informed consent
  • Have normal or corrected vision
  • Right handed
  • Willing to comply with all study procedures and be available for the duration of the study
  • Speak and understand English
  • Not color blind
  • Acceptable suicide risk as determined by less than 5 on the Depression Symptom Index Suicidality Subscale (DSI-SS)
  • A diagnosis of major depressive disorder (current episode) on the Structured Clinical Interview for the DSM-5 (SCID-5)
  • Between the ages of 18 and 65

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Florida State University
Coordinator of this site? Confirm its status
TallahasseeUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.